Viking Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Go back to Viking Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 29.21 -0.15 (0.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.36 | 52 Week High | $5.17 | |||
| Open | $29.57 | 52 Week Low | $0.94 | |||
| Day High | $29.68 | P/E | N/A | |||
| Day Low | $29.07 | EPS | $0.00 | |||
| Volume | 247,177 | |||||
